XML 27 R35.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Stock-Based Compensation (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2019
Dec. 31, 2018
Share-based Payment Arrangement [Abstract]    
Summary of Stock Options Activity

The following is a summary of stock options activity during the nine months ended September 30, 2019:

 

     Options Outstanding  
     Number of
Options
    Weighted-
Average
Exercise
Price
     Weighted-
Average
Remaining
Contractual
Life (years)
     Aggregate
Intrinsic
Value
 

Balance—January 1, 2019

     1,867,747     $ 9.01        9.64      $ 19,573,295  

Options granted

     195,975     $ 9.49        

Options exercised

     (487   $ 4.14         $ 1,630  

Options cancelled

     (165,622   $ 8.76        
  

 

 

         

Balance—September 30, 2019

     1,897,613     $ 9.10        9.02      $ 498,451  
  

 

 

         

Exercisable as of September 30, 2019

     218,096     $ 6.31        7.55      $ 359,753  
  

 

 

         

Vested and expected to vest as of September 30, 2019

     1,954,263     $ 9.13        8.75      $ 498,451  
  

 

 

         

The following is a summary of stock options activity during the year-ended December 31, 2018:

 

     Options Outstanding  
     Number of
Options
    Weighted-Average
Exercise Price
     Weighted-Average
Remaining
Contractual Life
(years)
     Aggregate
Intrinsic Value
 

Balance—January 1, 2018

     437,400     $ 6.01        

Options granted

     1,547,938     $ 9.72        

Options exercised

     (4,465   $ 4.13         $ 14,410  

Options cancelled

     (113,126   $ 7.02        
  

 

 

   

 

 

       

Balance—December 31, 2018

     1,867,747     $ 9.01        9.64      $ 19,573,295  
  

 

 

   

 

 

       

Exercisable as of December 31, 2018

     181,701     $ 5.85        7.65      $ 2,480,184  

Vested and expected to vest as of December 31, 2018

     1,867,747     $ 9.01        9.64      $ 19,573,295  
Summary of Weighted Average Assumptions Used in Black-Scholes Option-Pricing Model to Determine Grant Fair Value

The following are weighted-average assumptions used in the Black-Scholes option-pricing model to determine grant fair value:

 

     September 30,
2018
    September 30,
2019
 
     Weighted-
Average
    Weighted-
Average
 

Expected term (in years)

     0.00       5.77  

Volatility

     0.00     66.72

Risk-free interest rate

     0.00     1.76

Dividend Yield

     0.000       0.000  

The following are weighted-average assumptions used in the Black-Scholes option-pricing model with to determine grant fair value:

 

     2017     2018  
     Weighted-
Average
    Weighted-
Average
 

Expected term (in years)

     5.91       5.73  

Volatility

     53.51     55.06

Risk-free interest rate

     2.16     2.59

Dividend Yield

     0.000       0.000  
Summary of Restricted Stock Activity

A summary of restricted stock activity within the Company’s equity plans and changes for the nine months ended September 30, 2019, is as follows:

 

Restricted Stock Awards

   Shares      Weighted
Average Grant-
Date Fair Value
 

Nonvested at January 1, 2019

     —        $ —    

Granted

     2,645,123      $ 18.89  

Vested

     —        $ —    

Forfeited

     (69,141    $ 19.50  
  

 

 

    

 

 

 

Nonvested at September 30, 2019

     2,575,982      $ 18.87  
  

 

 

    

 

 

 
 
Summary of Total Stock-based Compensation Expense by Function

The following table summarizes the total stock-based compensation expense by function for the three and nine months ended September 30, 2018 and 2019:

 

     Three Months Ended
September 30,
     Nine Months Ended
September 30,
 
         2018              2019              2018              2019      
     (in thousands)      (in thousands)  

Sales and distribution expenses

     5        1,617        11        2,533  

Research and development expenses

     8        1,327        21        1,878  

General and administrative expenses

     128        4,772        450        7,424  
  

 

 

    

 

 

    

 

 

    

 

 

 

Total stock-based compensation expense

   $ 141      $ 7,716      $ 482      $ 11,835